96752 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
CYCLIC AGONISTS AND ANTAGONISTS OF C5A RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
#302Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
#303Cyclic Peptides As G-Protein Coupled Receptor Antagonists
#304Mutagenized strain of and a method of preparing a compound from the mutagenized strain
#305PLATELET AGGREGATION INHIBITORS
#306Alpha helical mimics, their uses and methods for their production
#307Phalloidin derivatives and methods for their synthesis
#308Melanocortin-1 receptor-specific cyclic peptides
#309Cyclic-GluR6 analogs, methods of treatment and use
#310Triazole macrocycle systems
#311AZACYCLOHEXAPEPTIDE OR ITS PHARMACEUTICAL ACCEPTABLE SALT, PREPARING METHOD AND USE THEREOF
#312ECHINOCANDIN DERIVATIVES
#313Melanocortin receptor-specific peptides
#314High penetration prodrug compositions of peptides and peptide-related compounds
#315Separation and/or purification of Bfrom C
#316PEPTIDOMIMETIC MACROCYCLES
#317Lactam-bridged melanocortin receptor-specific peptides
#318Method for the preparation of cyclopeptides
#319Alpha-helix mimetics and methods relating to the treatment of fibrosis
#320Melanocortin receptor-specific peptides
#321Peptidomimetic macrocycles
#322Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
#323PSEUDACYCLIN AND METHOD OF INDICATION OF A FUNGUS PSEUDALLESCHERIA BOYDII
#324Triazole macrocycle systems
#325Novel Peptides and Uses Thereof
#326TEMPLATE-FIXED PEPTIDOMIMETICS
#327Lipopeptide compounds and their use
#328Antitumoral compounds
#329Antiviral agents
#330Cyclized NGR peptide compounds, compositions, and methods of their use
#331System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity
#332Synthetic pathway enzymes for the production of argyrins
#333Melanocortin receptor-specific peptides for treatment of sexual dysfunction
#334METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#335C5a Receptor Antagonists
#336CYCLIC PEPTIDES AS G-PROTEIN COUPLED RECEPTOR ANTAGONISTS
#337Melanocortin receptor-specific peptides
#338Cyclic peptides comprising at least one aza-β3-aminoacyl residue and their uses
#339Antitumoral compounds
#340Antibiotics and Methods For Producing Them
#341PROTEASE INHIBITION
#342PROCESS FOR THE PREPARATION OF ECHINOCANDIN DERIVATIVES
#343Processes for preparing high purity aza cyclohexapeptides
#344POLYPEPTIDE COMPOUND
#345Purification process for lipopeptides
#346PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES
#347Methods for preparing internally constrained peptides and peptidomimetics
#34868GA-Labeled Peptide-Based Radiopharmaceuticals
#349Growth factor binding molecules
#350Radiofluorination methods
#351Melanocortin receptor ligands modified with hydantoin
#352Process for preparation of Caspofungin acetate
#353Process for synthesizing cyclic peptide compound
#354Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds
#355Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases
#356PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES
#357Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
#358CYCLIC PEPTIDE CXCR4 ANTAGONISTS
#359Cyclic peptide compositions for treatment of sexual dysfunction
#360Template-fixed peptidomimetics
#361Process for the manufacture of peptides
#362BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES
#363METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#364Caspofungin free of caspofungin impurity A
#365Process for preparing pharmaceutical compound and intermediates thereof
#366High penetration prodrug compositions of peptides and peptide-related compounds
#367Caspofungin free of caspofungin Co
#368Echinocandin/carbohydrate complexes
#369Presentation of Recognition Motifs by a Multivalent Matrix Grafted Onto a Solid Support
#370Alpha-helix mimetics and methods relating to the treatment of fibrosis
#371CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
#372CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS
#373Lysobactin amides
#374Process for the preparation of bicyclic peptide compounds
#375Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering
#376Peptides for Use In Treating Obesity
#377DEUTERIUM-ENRICHED CASPOFUNGIN
#378TRANSMUCOSAL DELIVERY OF PEPTIDE DERIVATIVES
#379Process and Intermediates for the Synthesis of Caspofungin
#380Composition and method for the treatment of diseases affected by histone deacetylase inhibitors
#381Peptides for Use in the Treatment of Obesity
#382Cyclic peptide CXCR4 antagonists
#383Methods for the synthesis of cyclic peptides
#384Triazole macrocycle systems
#385Alpha helical mimics, their uses and methods for their production
#386Cyclic Peptide Isolation by Spray Drying
#387Click chemistry-derived cyclic peptidomimetics as integrin markers
#388METHODS RELATING TO THE TREATMENT OF FIBROSIS
#389C5a Receptor Antagonist
#390METHODS RELATING TO THE TREATMENT OF FIBROSIS
#391Purification processes for echinocandin-type compounds
#392Kahalalide Compositions for the Treatment of Psoriasis
#393Method for the deacylation of lipopeptides
#394Cyclic nonapeptide amides
#395Antiinfective Lipopeptides
#396Hair growth promoting oligopeptides
#397Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof
#398REDOX-STABLE, NON-PHOSPHORYLATED CYCLIC PEPTIDE INHIBITORS OF SH2 DOMAIN BINDING TO TARGET PROTEIN, CONJUGATES, THEREOF, COMPOSITIONS AND METHODS OF SYNTHESIS AND USE
#399PROCESS FOR THE PREPARATION OF CYCLIC PEPTIDES
#400Strains belonging to the genus Paenibacillus and method of controlling plant disease by using these strains or culture thereof
#401Peptides for use in treating obesity
#402Peptide conjugates
#403Methods for preparing internally constrained peptides and peptidomimetics
#404Conjugates And Therapeutic Uses Thereof
#405Dabderivatives of lipopeptide antibiotics and methods of making and using the same
#406Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
#407New antitumoral compounds
#408Process for the preparation of echinocandin derivatives
#409Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
#410Stationary phases and a purification process using the stationary phases
#411Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
#412Cyclic peptides as G-protein-coupled receptor antagonists
#413Compounds and methods for modulating cell adhesion
#414C5a receptor antagonists
#415Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors
#416Cyclic peptide compositions for treatment of sexual dysfunction
#417Echinocandin/carbohydrate complexes
#418Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds
#419Capreomycin derivatives and their use as antibacterials
#420Substances K01-B0171 and process for producing the same
#421Growth factor binding molecules
#422Derivatives of echinocandine, their preparation process and their use as antifungals
#423Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
#424Methods for preparing internally constrained peptides and peptidomimetics
#425Cyclic peptides for treatment of cachexia
#426Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
#427Conformationally constrained C-backbone cyclic peptides
#428Production method for iturin a and its homologues
#429Binding moieties for fibrin
#430Compound
#431Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
#432Process
#433Echinocandin cyclic peptide derivatives
#434Cyclic peptide antifungal agents and process for preparation thereof
#435Depsipeptide and congeners thereof for use as immunosuppressants
#436Compositions of lipopeptide antibiotic derivatives and methods of use thereof
#437Process for the preparation of cyclic peptides
#438Carboxamide and amino derivatives and methods of their use
#439Carboxamide and amino derivatives and methods of their use
#440Anti-microbial peptides and compositions
#441Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
#442Helicomimetics and stabilized lxxll peptidomimetics
#443Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds
#444Linear and cyclic melanocortin receptor-specific peptides
#445Process for the preparation of echinocandin derivatives
#446New compound
#447Process for producing trunkamide a compounds
#448New compound